# FDA Warning Letter: R3 Medical Companies
> 2026-08-25 · Center for Biologics Evaluation and Research (CBER) · `43b840185f4a18dd`
## Letter
- **Company:** R3 Medical Companies
- **Posted Date:** 2026-08-25
- **Letter Issue Date:** 2026-08-14
- **Issuing Office:** Center for Biologics Evaluation and Research (CBER)
## Subject
Unapproved New Drugs/Unlicensed Biological Product Violations
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · MORVS · CC0 1.0*